<DOC>
	<DOCNO>NCT01510561</DOCNO>
	<brief_summary>90Y-hPAM4 administered weekly 3 week combine 4 weekly dos gemcitabine ass . This dose escalation study 90Y-hPAM4 ass dose safe effective 3rd line treatment patient metastatic pancreatic cancer . Patients follow weekly 12 week afterwards 1 year .</brief_summary>
	<brief_title>A Study Fractionated 90Y-hPAM4 Plus Gemcitabine Pancreatic Cancer Patients Receiving Least 2 Prior Therapies .</brief_title>
	<detailed_description />
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>Male female patient , ≥ 18 year age , able understand give write informed consent Histologically cytologically confirm pancreatic adenocarcinoma Stage IV ( metastatic ) disease , include patient underwent surgery incomplete resection Previously treat receive two prior treatment regimen advance disease Karnofsky performance status ≥ 60 % ( Appendix A ) Expected survival ≥ 3 month At least 4 week beyond major surgery , 2 week beyond chemotherapy , radiotherapy , experimental treatment At least 2 week beyond corticosteroid , except low dos ( i.e. , 20 mg/day prednisone equivalent ) treat nausea illness rheumatoid arthritis Adequate hematology without ongoing transfusional support ( hemoglobin &gt; 9 g/dL , ANC &gt; 1,500 per mm3 , platelet &gt; 100,000 per mm3 ) Adequate renal hepatic function ( creatinine bilirubin ≤ 1.5 X IULN , AST ALT ≤ 2.0 X IULN [ 5.0 X IULN due liver metastasis ] ) Otherwise , toxicity study entry ≤ Grade 1 NCI CTC v3.0 recover baseline discuss agree Immunomedics ' Medical Monitor . Women pregnant lactate Women childbearing potential fertile men unwilling use effective contraception study conclusion 12week posttreatment evaluation period Known metastatic disease central nervous system Presence bulky disease ( define single mass &gt; 10 cm great dimension ) Patients &gt; Grade 2 nausea vomit and/or sign intestinal obstruction Prior radiation dose &gt; 3,000 cGy liver , &gt; 2,000 cGy lung kidneys prior external beam irradiation field include 30 % red marrow Patients nonmelanoma skin cancer carcinoma situ cervix exclude , patient prior malignancy must least 3year disease free interval Patients know HIV positive , hepatitis B positive , hepatitis C positive Known history active coronary artery disease , unstable angina , myocardial infarction , congestive heart failure present within 6 month , cardiac arrhythmia ( stable atrial fibrillation ) require antiarrhythmia therapy Known history active COPD , moderatetosevere respiratory illness present within 6 month Known autoimmune disease presence autoimmune phenomenon ( except rheumatoid arthritis require low dose maintenance corticosteroid ) Infection require intravenous antibiotic use within 1 week Other concurrent medical psychiatric condition , Investigator 's opinion , may likely confound study interpretation prevent completion study procedure followup examination</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>metastatic pancreatic adenocarcinoma</keyword>
	<keyword>pancreatic cancer</keyword>
	<keyword>metastatic pancreatic cancer</keyword>
</DOC>